General Information of Drug (ID: DMX71K9)

Drug Name
1-(3,4-dichlorobenzyl)-1H-indole-2,3-dione Drug Info
Synonyms
Apoptosis Activator 2; 79183-19-0; 1-(3,4-Dichlorobenzyl)-1H-indole-2,3-dione; Apoptosis Activator II; 1-(3,4-dichlorobenzyl)indoline-2,3-dione; MDK83190; 1-[(3,4-dichlorophenyl)methyl]indole-2,3-dione; J-503075; 1H-Indole-2,3-dione,1-[(3,4-dichlorophenyl)methyl]-; SR-01000411093; ApoptosisActivator2; AC1LYJSJ; Tocris-2098; AC1Q3JHQ; CBMicro_042945; Isatin-based compound, 16; CHEMBL375126; SCHEMBL5426477; BDBM22796; CHEBI:92273; KS-00001DBG; CTK5E6556; cid_1901244; DTXSID30365533; EX-A147; AOB2639; MolPort-002-181-853; HMS3651L12
Cross-matching ID
PubChem CID
1901244
ChEBI ID
CHEMBL375126
CAS Number
CAS 79183-19-0
TTD Drug ID
D07EDG

Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)

Term Name NES FDR q-val Tag % Leading Edge Genes
DNA replication 1.97 2.06e-2 34/36 (94.44%) POLE2;POLE3;PCNA;...
African trypanosomiasis 1.96 1.03e-2 32/37 (86.49%) F2RL1;HBB;PRKCA;...
Cell cycle 1.95 6.85e-3 110/124 (88.71%) CDKN2C;TGFB1;CCNB2;...
Salivary secretion 1.78 2.57e-2 76/93 (81.72%) LYZ;GNAS;FXYD2;...
Mismatch repair 1.77 2.88e-2 22/23 (95.65%) PCNA;RFC3;SSBP1;...
Neutrophil extracellular trap formation 1.76 2.74e-2 101/189 (53.44%) ELANE;SRC;PRKCA;...
Pancreatic secretion 1.74 2.64e-2 87/102 (85.29%) GNAS;CA2;FXYD2;...
Adrenergic signaling in cardiomyocytes 1.74 2.57e-2 130/150 (86.67%) GNAS;FXYD2;PRKCA;...
Cardiac muscle contraction 1.73 2.63e-2 64/87 (73.56%) FXYD2;ACTC1;CACNA2D3;...
Glycosaminoglycan biosynthesis 1.70 4.01e-2 40/58 (68.97%) CHST15;EXT1;GLCE;...
Pentose phosphate pathway -1.84 3.22e-2 25/30 (83.33%) PGLS;PFKL;RPIA;...
Metabolism of xenobiotics by cytochrome P450 -1.86 1.45e-2 49/77 (63.64%) UGT2B15;SULT2A1;GSTP1;...
Steroid hormone biosynthesis -1.91 1.93e-2 43/61 (70.49%) UGT2B28;CYP11B1;AKR1C3;...
×

Pharmacogenomic Perturbation Across Diseases and Tissues

Bone
Osteosarcoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
U-2 OS CVCL_0042 Homo sapiens 10uM 6H
Breast
Breast adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
MCF7 CVCL_0031 Homo sapiens 10uM 6H, 24H
Colon
Colorectal adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HT-29 CVCL_0320 Homo sapiens 10uM 6H
Hematopoietic system
Normal
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
ASC CVCL_U602 Homo sapiens 10uM 24H
Kidney
Normal (Immortalized)
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HA1E CVCL_0284 Homo sapiens 10uM 6H, 24H
Liver
Hepatoblastoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
Hep G2 CVCL_0027 Homo sapiens 10uM 6H
Lung
Lung adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A549 CVCL_0023 Homo sapiens 10uM 6H, 24H
Non-small cell lung carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HCC515 CVCL_5134 Homo sapiens 10uM 6H, 24H
Prostate
Prostate carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
PC-3 CVCL_0035 Homo sapiens 10uM 6H, 24H
VCaP CVCL_2235 Homo sapiens 10uM 6H, 24H
Skin
Melanoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A-375 CVCL_0132 Homo sapiens 10uM 6H